文献速递妇科

子宫内膜异位症病灶分布随就诊年龄的变化:一项国际多中心数据库研究

Endometriosis lesion distribution by age at presentation: an international multicentre database study.
PubMed 文献 · Hum Reprod · 2026-01-01

结果显示浅表病灶随年龄线性下降,深部病灶和卵巢子宫内膜瘤在30岁左右达峰后趋于平台。

要点

  • 浅表病灶几率每年下降3%,深部病灶在约30-33岁前逐年增加后平台。
  • 卵巢子宫内膜瘤几率在10岁时每年增20%,患病率高峰约40.9岁。
  • 受累部位总数在32.8岁前每年增0.12个,此后与年龄无关。

核心结论

  • 年长患者深部结节和卵巢子宫内膜瘤更多,浅表病灶更少,但深部病灶增加在30岁左右趋于平台。

研究设计与样本

  • 采用非二次、二次和分段logistic回归模型分析病灶患病率随年龄的变化,校正既往内异症切除史。

主要发现

  • 手术时平均年龄35.9岁(SD 7.4)。
  • 浅表内异症几率随年龄线性下降,每年3%(aOR 0.97,95%CI 0.96-0.97,P<0.001)。
  • 肠内异症每年增7%(aOR 1.07,95%CI 1.05-1.09,P<0.001)至32.9岁(95%CI 30.5-35.3);深部侧壁病每年增7%(aOR 1.07,95%CI 1.05-1.09,P<0.001)至31.3岁(95%CI 29.2-33.5);宫骶韧带病每年增4%(aOR 1.04,95%CI 1.02-1.06,P<0.001)至33岁(95%CI 29.3-36.6)。
  • 深部膀胱病每年增12%(aOR 1.12,95%CI 1.04-1.22,P=0.005)至28.2岁(95%CI 25.8-30.6),之后每年降2%(aOR 0.98,95%CI 0.97-1.00,P=0.007)。
  • 卵巢子宫内膜瘤采用二次模型描述,10岁时几率每年增20%(aOR 1.20,95%CI 1.16-1.23,P<0.001),患病率高峰40.9岁(95%CI 34.1-47.7,P<0.001);受累部位总数每年增0.12个(95%CI 0.10-0.14,P<0.001)至32.8岁,此后与年龄无关。

临床怎么用

  • 临床评估不同年龄内异症患者时,应警惕年长患者深部病灶和卵巢子宫内膜瘤可能,年轻患者浅表病灶更常见。
  • 深部病灶患病率在30岁左右达平台,提示疾病进展并非无限持续。

局限性

  • 横断面设计仅纳入因疼痛接受切除及直肠旁分离手术的患者,不能代表无症状或未手术患者。
  • 无法提供个体水平的疾病进展数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How does the frequency and location of endometriosis lesions observed at laparoscopy vary with patient age? SUMMARY ANSWER: We find that older patients have more deep lesions and ovarian endometriomas at laparoscopy, although this plateaus around 30 years of age. WHAT IS KNOWN ALREADY: The natural history and aetiology of endometriosis remain uncertain, with evidence of progression, spontaneous regression, and stable disease in various studies. STUDY DESIGN, SIZE, DURATION: Cross-sectional analysis of a prospectively collected surgical registry, including data from 104 accredited endometriosis centres across 7 countries, with 14 670 cases in total. PARTICIPANTS/MATERIALS, SETTING, METHODS: We analysed data from the British Society for Gynaecological Endoscopy (BSGE) endometriosis centres database, a multicentre international prospective cohort of patients undergoing surgery for deep endometriosis. We included all patients aged 10-55 years from 2009 to 2021. The change in lesion prevalence with age was modelled using three different logistic regression models-non-quadratic, quadratic, and segmented, adjusted for whether they had undergone endometriosis excision in the past. MAIN RESULTS AND THE ROLE OF CHANCE: We identified 14 670 cases from 104 centres across 7 countries. The mean age at the time of surgery was 35.9 years (SD 7.4). The odds of superficial endometriosis decreased linearly with age by 3% per year (adjusted odds ratio (aOR) 0.97, 95% CI 0.96-0.97, P < 0.001). The following increased before plateauing: bowel endometriosis increased by 7% per year (aOR 1.07, 95% CI 1.05-1.09, P < 0.001) until 32.9 years of age (95% CI 30.5-35.3); deep sidewall disease increased by 7% per year (aOR 1.07, 95% CI 1.05-1.09, P < 0.001) until 31.3 years (95% CI 29.2-33.5); and uterosacral disease increased by 4% per year (aOR 1.04, 95% CI 1.02-1.06, P < 0.001) until 33 years (95% CI 29.3-36.6). Deep bladder disease increased by 12% per year (aOR 1.12, 95% CI 1.04-1.22, P = 0.005) until 28.2 (95% CI 25.8-30.6) years, after which the odds decreased by 2% per year (aOR 0.98, 95% CI 0.97-1.00, P = 0.007). Ovarian endometrioma was best described by a quadratic model, with a starting increase in odds of endometrioma of 20% per year at 10 years (aOR 1.20, 95% CI 1.16-1.23, P < 0.001), and a peak prevalence at 40.9 years of age (95% CI 34.1-47.7, P < 0.001). The total number of sites affected by endometriosis increased by 0.12 sites per year (95% CI 0.10-0.14, P < 0.001) until 32.8 years of age, with no correlation with age after this point. LIMITATIONS, REASONS FOR CAUTION: This cross-sectional study only includes patients undergoing excision with pararectal dissection for the treatment of pain, so does not capture patients who do not undergo such surgery, including asymptomatic patients, and cannot provide data on potential disease progression on an individual level. WIDER IMPLICATIONS OF THE FINDINGS: This study supports existing evidence suggesting that older patients with endometriosis have more deep nodules and endometriomas and less superficial disease. STUDY FUNDING/COMPETING INTEREST(S): No funding was provided for this study. K.V. reports consulting fees from Eli Lilly, Gedeon Richter, Gesynta, and Rickett (all paid to institution); speakers' fees from Gedeon Richter and Reckitt (both paid to institution); membership of the Medical Advisory Panel of Endometriosis UK (unpaid); past presidency of the International Association for the Study of Pain (IASP) Special Interest Group (SIG) on Abdominal and Pelvic Pain (unpaid). TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lewin J, Vashisht A, Langan D, et al. Endometriosis lesion distribution by age at presentation: an international multicentre database study. Hum Reprod. 2026. PMID: 41818725. doi:10.1093/humrep/deag033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。